Crossmark Global Holdings’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,849
Closed -$206K 1279
2026
Q1
$206K Hold
8,849
﹤0.01% 1190
2025
Q4
$392K Buy
8,849
+47
+0.5% +$2.64K 0.01% 927
2025
Q3
$644K Buy
8,802
+501
+6% +$32.7K 0.01% 792
2025
Q2
$509K Buy
8,301
+159
+2% +$8.87K 0.01% 881
2025
Q1
$472K Buy
8,142
+69
+0.9% +$4.36K 0.01% 890
2024
Q4
$431K Buy
8,073
+17
+0.2% +$832 0.01% 895
2024
Q3
$351K Sell
8,056
-10,121
-56% -$338K 0.01% 1008
2024
Q2
$509K Sell
18,177
-242
-1% -$6.38K 0.01% 825
2024
Q1
$496K Buy
18,419
+1,376
+8% +$39.2K 0.01% 875
2023
Q4
$478K Buy
17,043
+4,153
+32% +$98.1K 0.01% 868
2023
Q3
$289K Buy
12,890
+34
+0.3% +$928 0.01% 1032
2023
Q2
$456K Buy
+12,856
New +$428K 0.01% 895

Other funds holding DOCS

Crossmark Global Holdings's DOCS Position: Q2 2026 in Review

Crossmark Global Holdings sold out of Doximity (DOCS) in Q2 2026, closing a stake of 8,849 shares — an estimated $206K sold.

Crossmark Global Holdings first reported a position in DOCS in Q2 2023 and held it in 12 quarters. The position peaked at $644K in Q3 2025. 43 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Crossmark Global Holdings reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
  • Crossmark Global Holdings sold 8,849 Doximity shares in Q2 2026, an estimated $206K.
  • Crossmark Global Holdings first reported a position in Doximity in Q2 2023 and held it in 12 quarters.
  • Crossmark Global Holdings's Doximity position peaked at $644K in Q3 2025.
  • 43 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.